Want to join the conversation?
$AXP's billed business growth was 5% on an FX-adjusted basis during 4Q15, consistent with 3Q15 and below the full year figure of 6%. Overall, billings growth rate decelerated modestly during 2015, while the company has anticipated a sequential strengthening.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)